Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05572073 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Otoferlin Gene-mediated Hearing Loss Natural History Study

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv11
  2. Site details revised at 1 of 10 sitesv10
  3. Study sites: 9 to 10v9
  4. Re-verified, no change to tracked fieldsv8
  5. Study sites: 8 to 9v7
Show 5 earlier versionsHide 5 earlier versions
  1. Study sites: 5 to 8v6
  2. Site details revised at 1 of 5 sitesv5
  3. Study Identification, Study Status, Contacts/Locationsv4
  4. Collaborators expanded, about 4 wordsv3
  5. Study sites: 4 to 5v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a retrospective and prospective longitudinal study in participants with Otoferlin Gene-Mediated Hearing Loss.
Trial Details
NCT Number NCT05572073
Lead Sponsor Akouos, Inc.
Collaborators: Eli Lilly and Company
Conditions
(from sponsor)		 Sensorineural Hearing Loss, Bilateral
Related terms Auditory neuropathy, Hearing Loss, Sensorineural
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov